PSGR promotes prostatic intraepithelial neoplasia and prostate cancer xenograft growth through NF-κB

Oncogenesis

Volumn 3, Issue , 2014, Pages

  Rodriguez, M ^a   Luo, W ^a   Weng, J ^a   Zeng, L ^a   Yi, Z ^b   Siwko, S ^a   Liu, M ^a,b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

8 [4 (1 AMINOCYCLOBUTYL)PHENYL] 9 PHENYL 1,2,4 TRIAZOLO[3,4 F][1,6]NAPHTHYRIDIN 3(2H) ONE; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTATE SPECIFIC G PROTEIN COUPLED RECEPTOR; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYCLOOXYGENASE 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROBASIN; RANTES; SMOOTH MUSCLE ACTIN; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LNCAP CELL LINE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR PROMOTION; TUMOR XENOGRAFT; CANCER GRADING; CANCER STAGING; CELL MIGRATION; EMBRYO; MALE; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; UPREGULATION;

MUS MUSCULUS;

EID: 84907342916     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2014.29     Document Type: Article

References (40)

1. Shen MM, Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 2010; 24: 1967-2000.
2. Giles GG. Epidemiological investigation of prostate cancer. Methods Mol Med 2003; 81: 1-19.
3. Borowsky AD, Dingley KH, Ubick E, Turteltaub KW, Cardiff RD, Devere-White R. Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model. Neoplasia 2006; 8: 708-715. (Pubitemid 44465522)
4. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7: 256-269. (Pubitemid 46486616)
5. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 1999; 155: 1985-1992.
6. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. New Engl J Med 2003; 349: 366-381. (Pubitemid 36886244)
7. Klein EA, Silverman R. Inflammation, infection, and prostate cancer. Curr Opin Urol 2008; 18: 315-319. (Pubitemid 351489383)
8. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545.
9. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005; 7: 211-217. (Pubitemid 40568680)
10. Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007; 117: 1175-1183. (Pubitemid 46718402)
11. Sfanos KS, De Marzo AM. Prostate cancer and inflammation: the evidence. Histopathology 2012; 60: 199-215.
12. Haverkamp J, Charbonneau B, Ratliff TL. Prostate inflammation and its potential impact on prostate cancer: a current review. J Cell Biochem 2008; 103: 1344-1353. (Pubitemid 351490705)
13. Perkins ND. The diverse and complex roles of NF-κB subunits in cancer. Nat Rev Cancer 2012; 12: 121-132.
14. Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat Immunol 2011; 12: 715-723.
15. Fraser CC. G protein-coupled receptor connectivity to NF-κB in inflammation and cancer. Int Rev Immunol 2008; 27: 320-350.
16. Ye RD. Regulation of nuclear factor kappaB activation by G-protein-coupled receptors. J Leukocyte Biol 2001; 70: 839-848. (Pubitemid 33151122)
17. Leitges M, Sanz L, Martin P, Duran A, Braun U, Garcia JF et al. Targeted disruption of the zetaPKC gene results in the impairment of the NF-κB pathway. Mol cell 2001; 8: 771-780. (Pubitemid 33030211)
18. Duran A, Diaz-Meco MT, Moscat J. Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation. EMBO J 2003; 22: 3910-3918. (Pubitemid 36975717)
19. Grabiner BC, Blonska M, Lin PC, You Y, Wang D, Sun J et al. CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{κ}B activation. Genes Dev 2007; 21: 984-996. (Pubitemid 46625646)
20. McAllister-Lucas LM, Ruland J, Siu K, Jin X, Gu S, Kim DS et al. CARMA3/Bcl10/MALT1-dependent NF-κB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proc Natl Acad Sci USA 2007; 104: 139-144. (Pubitemid 46067998)
21. Rawlings DJ, Sommer K, Moreno-Garcia ME. The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes. Nat Rev Immunol 2006; 6: 799-812. (Pubitemid 44631649)
22. Allavena P, Garlanda C, Borrello MG, Sica A, Mantovani A. Pathways connecting inflammation and cancer. Curr Opin Genet Dev 2008; 18: 3-10. (Pubitemid 351694444)
23. Dan HC, Adli M, Baldwin AS. Regulation of mammalian target of rapamycin activity in inactive prostate cancer cells by I kappa B kinase alpha. Cancer Res 2007; 67: 6263-6269. (Pubitemid 47037508)
24. Dan HC, Cooper MJ, Cogswell PC, Duncan JA, Ting JP, Baldwin AS. Akt-dependent regulation of NF-{κ}B is controlled by mTOR and Raptor in association with IKK. Genes Dev 2008; 22: 1490-1500. (Pubitemid 351793083)
25. Xia C, Ma W, Wang F, Hua S, Liu M. Identification of a prostate-specific G-protein coupled receptor in prostate cancer. Oncogene 2001; 20: 5903-5907. (Pubitemid 32937960)
26. Xu LL, Stackhouse BG, Florence K, Zhang W, Shanmugam N, Sesterhenn IA et al. PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer. Cancer Res 2000; 60: 6568-6572.
27. Weng J, Wang J, Hu X, Wang F, Ittmann M, Liu M. PSGR2, a novel G-protein coupled receptor, is overexpressed in human prostate cancer. Int J Cancer 2006; 118: 1471-1480.
28. Weng J, Ma W, Mitchell D, Zhang J, Liu M. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors. J Cell Biochem 2005; 96: 1034-1048. (Pubitemid 41688727)
29. Tang XL, Wang Y, Li DL, Luo J, Liu MY. Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets. Acta Pharmacol Sin 2012; 33: 363-371.
30. Wang J, Weng J, Cai Y, Penland R, Liu M, Ittmann M. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase. Prostate 2006; 66: 847-857.
31. Weng J, Wang J, Cai Y, Stafford LJ, Mitchell D, Ittmann M et al. Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers. Int J Cancer 2005; 113: 811-818. (Pubitemid 40101264)
32. Xu LL, Sun C, Petrovics G, Makarem M, Furusato B, Zhang W et al. Quantitative expression profile of PSGR in prostate cancer. Prostate Cancer Prostatic Dis 2006; 9: 56-61. (Pubitemid 43378871)
33. Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA et al. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 2004; 64: 2270-2305. (Pubitemid 38339483)
34. Park JH, Walls JE, Galvez JJ, Kim M, Abate-Shen C, Shen MM et al. Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol 2002; 161: 727-735. (Pubitemid 36142181)
35. Matsueda S, Wang M, Weng J, Li Y, Yin B, Zou J et al. Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy. PLoS ONE 2012; 7: e45756.
36. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883-899.
37. McCall P, Bennett L, Ahmad I, Mackenzie LM, Forbes IW, Leung HY et al. NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression. Br J Cancer 2012; 107: 1554-1563.
38. Suh J, Payvandi F, Edelstein LC, Amenta PS, Zong WX, Gelinas C et al. Mechanisms of constitutive NF-κB activation in human prostate cancer cells. Prostate 2002; 52: 183-200. (Pubitemid 34791221)
39. Sun HZ, Yang TW, Zang WJ, Wu SF. Dehydroepiandrosterone-induced proliferation of prostatic epithelial cell is mediated by NFKB via PI3K/AKT signaling pathway. J Endocrinol 2010; 204: 311-318.
40. Neuhaus EM, Zhang W, Gelis L, Deng Y, Noldus J, Hatt H. Activation of an olfactory receptor inhibits proliferation of prostate cancer cells. J Biol Chem 2009; 284: 16218-16225.